Fonte: Journal of Clinical Oncology. Nome do evento: Annual Meeting American Society of Clinical Oncology/ASCO. Unidade: FCF
Assuntos: NANOPARTÍCULAS, METÁSTASE NEOPLÁSICA
ABNT
GRAZIANI, Silvia Regina et al. Association of paclitaxel to lipid nanoparticles in the treatment of bone metastasis in patients with solid tumors. Journal of Clinical Oncology. Alexandria: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 20 ago. 2024. , 2017APA
Graziani, S. R., Almeida, L. M. de, Batistela, P. C., Maranhão, R. C., Vital, C. G., Morikawa, A. T., et al. (2017). Association of paclitaxel to lipid nanoparticles in the treatment of bone metastasis in patients with solid tumors. Journal of Clinical Oncology. Alexandria: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Graziani SR, Almeida LM de, Batistela PC, Maranhão RC, Vital CG, Morikawa AT, Fernandes HJ, Naime F de F, Fonseca RO da, Dias CAR, Almeida LR de, Azuaga Neto RF, Yamada KE, Abreu MSSG de, Pontes TC, D'Alvia Thiago, Ferreira RS, Velasquez ARE, Orias VU, Vanderlinde FG. Association of paclitaxel to lipid nanoparticles in the treatment of bone metastasis in patients with solid tumors. Journal of Clinical Oncology. 2017 ; 35( 2): e21631.[citado 2024 ago. 20 ]Vancouver
Graziani SR, Almeida LM de, Batistela PC, Maranhão RC, Vital CG, Morikawa AT, Fernandes HJ, Naime F de F, Fonseca RO da, Dias CAR, Almeida LR de, Azuaga Neto RF, Yamada KE, Abreu MSSG de, Pontes TC, D'Alvia Thiago, Ferreira RS, Velasquez ARE, Orias VU, Vanderlinde FG. Association of paclitaxel to lipid nanoparticles in the treatment of bone metastasis in patients with solid tumors. Journal of Clinical Oncology. 2017 ; 35( 2): e21631.[citado 2024 ago. 20 ]